A clear look at the 340B program: how hospitals generate revenue from drug discounts, why it has expanded, and the growing ...
A judge on Tuesday rejected a challenge from major pharmaceutical companies against Washington’s new law trying to reduce ...
2don MSNOpinion
Drug pricing malpractice
Careful analysis of the seemingly intractable problem of rising medical costs can typically be reduced to three things: 1) ...
New York lawmakers won't pass a 340B drug program protection bill this session, disappointing hospitals and health centers that rely on discounted medications.
On July 31, the US Department of Health and Human Services’ (HHS) Health Resources and Services Administration (HRSA) announced the availability of a new pilot program altering how pharmaceutical ...
Illinois lawmakers passed two bills balancing hospital protections and audits for the federal 340B drug program.
A federal court has blocked the implementation of the 340B rebate pilot, sparing safety-net hospitals from potential cash-flow crises and preserving upfront drug discounts for now. Revenue cycle ...
$3M in Seed Funding and Proven Pilots Accelerate Path to Maximizing Essential Revenue for Healthcare Providers Serving Communities in Need Healthcare providers purchased a record $66 billion in drugs ...
The federal 340B Drug Pricing Program ("340B Program") was created by Congress in 1992 through an amendment to the Public Health Service Act. [i] The program, which is administered by the Health ...
Utah is not exempt from a nationwide trend. Rising health care costs have crippled small businesses and working families. The crisis demands systemic change; on this, most Republicans and Democrats ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results